Gene Expression Analysis Markets, 2020-2025 Projections - ResearchAndMarkets.com

DUBLIN--()--The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global gene expression analysis market is currently experiencing strong growth. Looking forward, the market is expected to exhibit a CAGR of around 9% during 2020-2025.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development.

Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth. Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement.

Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth.

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, BGI, Bio-Rad Laboratories Inc., Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, Illumina, Inc., Oxford Gene Technology, Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., etc.

Key Questions Answered

  • How has the global gene expression analysis market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the products & services?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the capacity?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global gene expression analysis market and who are the key players?
  • What is the degree of competition in the market?

Key Topics Covered

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Gene Expression Analysis Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Products & Services

6.1 Consumables

6.2 Instruments

6.3 Services

7 Market Breakup by Technology

7.1 Polymerase Chain Reaction (PCR)

7.2 Next Generation Sequencing (NGS)

7.3 DNA Microarray

7.4 Sanger Sequencing

7.5 Others

8 Market Breakup by Capacity

8.1 Low-to Mid-Plex Gene Expression Analysis

8.2 High-Plex Gene Expression Analysis

9 Market Breakup by End-User

9.1 Pharmaceutical and Biotech companies

9.2 Academic Institutes and Research Centers

9.3 Others

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia-Pacific

10.4 Latin America

10.5 Middle East and Africa

11 SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Value Chain Analysis

12.1 Overview

12.2 Inbound Logistics

12.3 Operations

12.4 Outbound Logistics

12.5 Marketing and Sales

12.6 Service

13 Porters Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Competition

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

15.3.1 Agilent Technologies

15.3.1.1 Company Overview

15.3.1.2 Product Portfolio

15.3.1.3 Financials

15.3.1.4 SWOT Analysis

15.3.2 BGI

15.3.3 Bio-Rad Laboratories Inc.

15.3.4 Eurofins Scientific

15.3.5 F. Hoffmann-La Roche

15.3.6 GE Healthcare

15.3.7 Illumina Inc.

15.3.8 Oxford Gene Technology

15.3.9 Pacific Biosciences of California Inc.

15.3.10 Perkinelmer Inc.

15.3.11 Qiagen N.V.

15.3.12 Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/o03xf9

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900